AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 129 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $45,000,000 | +1476.7% | 752,003 | +640.0% | 0.02% | +1500.0% |
| Q3 2019 | $2,854,000 | +117.4% | 101,618 | +193.0% | 0.00% | 0.0% |
| Q2 2019 | $1,313,000 | +18.1% | 34,680 | +21.7% | 0.00% | – |
| Q1 2019 | $1,112,000 | -59.1% | 28,500 | -77.6% | 0.00% | -100.0% |
| Q4 2018 | $2,718,000 | +676.6% | 127,490 | +1343.8% | 0.00% | – |
| Q3 2018 | $350,000 | -3.8% | 8,830 | -7.1% | 0.00% | – |
| Q2 2018 | $364,000 | -76.0% | 9,508 | -81.2% | 0.00% | -100.0% |
| Q1 2018 | $1,518,000 | +450.0% | 50,532 | +471.9% | 0.00% | – |
| Q4 2017 | $276,000 | +26.0% | 8,836 | +13.1% | 0.00% | – |
| Q3 2017 | $219,000 | +1890.9% | 7,816 | +1209.2% | 0.00% | – |
| Q2 2017 | $11,000 | – | 597 | +3411.8% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 17 | -98.8% | 0.00% | – |
| Q3 2016 | $25,000 | – | 1,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |